Production of Proangiogenic Cytokines During Thalidomide Treatment of Multiple Myeloma
Anna Dmoszyńska(1 Military Clinical Hospital with Outpatient Clinic), Maria Soroka‐Wojtaszko, Marek Hus(Medical University of Lublin), Damian Domański(Medical University of Lublin), Jacek Roliński(Medical University of Lublin), Agnieszka Bojarska−Junak(Medical University of Lublin)
Cited by 37
Related Papers
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|2004|921
Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2007|556
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2024|162
Therapy‐related peripheral neuropathy in multiple myeloma patients
|Hematological Oncology|2014|70